piter Forum Elite
Topics: 34 Posts: 191
| | 05/05/04 - 12:32 PM  
 
   
 
|   #1 |
A 26-year-old white female presents to the outpatient clinic complaining of an expanding rash. Her social history is significant for recent backpacking along the Appalachian Trail in New England. The rash is localized to her upper back, and it appears erythematous and circular with central clearing. The patient recalls no tick bite. Doxycycline is initiated. What is the make-up of the vaccine recommended in endemic areas? A. Bacillus Calmette-Guerin (BCG) B. Live, attenuated bacterium (acid-fast negative) C. Outer-surface protein D. Polysaccharide conjugated to toxoid E. Toxoid F. Vi capsular polysaccharide.
|
| dxtxpx Forum Guru
Topics: 259 Posts: 1,233
| | 05/05/04 - 12:41 PM  
 
   
 
|   #2 |
Answer C) OSP
|
| asmi Forum Hero
Topics: 1043 Posts: 4,609
| | 05/05/04 - 12:44 PM  
 
   
 
|   #3 |
yep C ..lyme disease..and OSP,
|
| piter Forum Elite
Topics: 34 Posts: 191
| | 05/05/04 - 12:55 PM  
 
   
 
|   #4 |
correct
|
| dxtxpx Forum Guru
Topics: 259 Posts: 1,233
| | 05/05/04 - 12:57 PM  
 
   
 
|   #5 |
is this vaccine still available. i thought it was taken off the market. if thats the case, its not relative for step1. do u know anything about it?
|
|
| |
| | | | | |